Voyager Therapeutics Inc [NASDAQ: VYGR] loss 0.00% or 0.0 points to close at $3.2 with a heavy trading volume of 303242 shares.
It opened the trading session at $3.2, the shares rose to $3.2799 and dropped to $3.165, the range by which the price of stock traded the whole day. The daily chart for VYGR points out that the company has recorded -42.75% loss over the past six months.
If we look at the average trading volume of 566.09K shares, VYGR reached to a volume of 303242 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Voyager Therapeutics Inc [VYGR]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VYGR shares is $15.78 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VYGR stock is a recommendation set at 1.09. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cantor Fitzgerald have made an estimate for Voyager Therapeutics Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on January 10, 2025. While these analysts kept the previous recommendation, Citigroup raised their target price to Buy. The new note on the price target was released on December 02, 2024, representing the official price target for Voyager Therapeutics Inc stock. Previously, the target price had yet another raise from $7 to $11, while Wedbush kept a Outperform rating on VYGR stock.
The Price to Book ratio for the last quarter was 0.65, with the Price to Cash per share for the same quarter was set at 4.27.
Trading performance analysis for VYGR stock
Voyager Therapeutics Inc [VYGR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.74. With this latest performance, VYGR shares dropped by -2.44% in over the last four-week period, additionally sinking by -42.75% over the last 6 months – not to mention a drop of -43.56% in the past year of trading.
Voyager Therapeutics Inc [VYGR]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Voyager Therapeutics Inc [VYGR] shares currently have an operating margin of -152.03% and a Gross Margin at 93.21%. Voyager Therapeutics Inc’s Net Margin is presently recorded at -126.49%.
Return on Equity for this stock declined to -20.59%, with Return on Assets sitting at -20.59%.
Voyager Therapeutics Inc [VYGR]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for VYGR. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Voyager Therapeutics Inc go to -12.46%.
An analysis of Institutional ownership at Voyager Therapeutics Inc [VYGR]
There are presently around $63.43%, or 76.05% of VYGR stock, in the hands of institutional investors. The top three institutional holders of VYGR stocks are: BLACKROCK INC. with ownership of 5.31 million shares, which is approximately 9.2038%. ARMISTICE CAPITAL, LLC, holding 5.2 million shares of the stock with an approximate value of $$41.13 million in VYGR stocks shares; and ARMISTICE CAPITAL, LLC, currently with $$30.99 million in VYGR stock with ownership which is approximately 6.7869%.
